Partnered with TATA Capital and NTT DATA Japan, the leading medical imaging AI startup, DeepTek.ai, has announced that it has received clearance from the US Food and Drug Administration (FDA) for its revolutionary chest X-ray AI solution — CXR Analyzer.
